Mark Bachleda - Oct 8, 2021 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Commercial Officer
Signature
/s/ J. Mel Sorensen, Attorney-in-Fact for Mark J. Bachleda
Stock symbol
GRTX
Transactions as of
Oct 8, 2021
Transactions value $
$0
Form type
4
Date filed
10/12/2021, 08:23 PM
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +200K $0.00 200K Oct 8, 2021 Common Stock 200K $7.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter.